{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:17Z","timestamp":1791323657826,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273622"],"award-info":[{"award-number":["82273622"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jceh.2026.103601","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:54:41Z","timestamp":1782888881000},"page":"103601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Analysis of Gut Microbiota and Bile Acid Metabolism Reveals a Distinct Pro-fibrotic Profile in Non-obese Patients With Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongdui","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-0392","authenticated-orcid":false,"given":"Honghui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103601_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103601_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib3","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.3350\/cmh.2022.0350","article-title":"Comparison between obese and non-obese nonalcoholic fatty liver disease","volume":"29","author":"Chan","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016","volume":"288","author":"Zou","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jceh.2026.103601_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/diagnostics12040801","article-title":"Clinical and laboratory characteristics of normal weight and obese individuals with non-alcoholic fatty liver disease","volume":"12","author":"Trifan","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.jceh.2026.103601_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11901-016-0302-1","article-title":"Lean NAFLD: an underrecognized outlier","volume":"15","author":"Wattacheril","year":"2016","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.jceh.2026.103601_bib7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s40618-022-01792-9","article-title":"Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD","volume":"45","author":"Ciardullo","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.jceh.2026.103601_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12020-023-03351-5","article-title":"Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis","volume":"85","author":"Huang","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.jceh.2026.103601_bib9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.12669\/pjms.41.6.12044","article-title":"Effect of lean status on the mortality of patients with non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"41","author":"Miao","year":"2025","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jceh.2026.103601_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/jgh.14056","article-title":"Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease","volume":"33","author":"Koo","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/cells8111358","article-title":"Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression","volume":"8","author":"Gottlieb","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2026.103601_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"key":"10.1016\/j.jceh.2026.103601_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jceh.2026.103601_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/ijms17030300","article-title":"Gut microbiota and nonalcoholic fatty liver disease: insights on mechanism and application of metabolomics","volume":"17","author":"He","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103601_bib16","article-title":"From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients","volume":"15","author":"Huang","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jceh.2026.103601_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/aihb.aihb_19_25","article-title":"A review of the gut microbiome and its role in non-alcoholic fatty liver disease","volume":"16","author":"Alfhaid","year":"2026","journal-title":"Adv Hum Biol"},{"key":"10.1016\/j.jceh.2026.103601_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jceh.2026.103601_bib19","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jceh.2026.103601_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jceh.2026.103601_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2026.108282","article-title":"Bile resistance mechanisms in probiotics: from structural adaptation to metabolic regulation","volume":"76","author":"Hu","year":"2026","journal-title":"Food Biosci"},{"key":"10.1016\/j.jceh.2026.103601_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.102503","article-title":"Gut microbiota and genetic polymorphisms appear to drive disease expression of nonalcoholic fatty liver disease in lean individuals","volume":"15","author":"Anirvan","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib23","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1038\/s41467-020-18754-5","article-title":"Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2026.103601_bib24","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon-157416","article-title":"Effects of silymarin combined with herbal medicine on Th17\/Treg cell imbalance and inflammatory response in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial","volume":"25","author":"Mai","year":"2025","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jceh.2026.103601_bib25","first-page":"177","article-title":"Guideline of prevention and treatment of nonalcoholic fatty liver disease (2018 china)","volume":"21","author":"Fan","year":"2018","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jceh.2026.103601_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103601_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjac.2022.100175","article-title":"Characterization and quantification of representative bile acids in ileal contents and feces of diet-induced obese mice by UPLC-MS\/MS","volume":"51","author":"Zhu","year":"2023","journal-title":"Chin J Anal Chem"},{"key":"10.1016\/j.jceh.2026.103601_bib28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nmeth.2604","article-title":"UPARSE: highly accurate OTU sequences from microbial amplicon reads","volume":"10","author":"Edgar","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.jceh.2026.103601_bib29","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1128\/AEM.00062-07","article-title":"Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jceh.2026.103601_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD-a systematic review and meta-analysis","volume":"21","author":"Tang","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103601_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111315","article-title":"Adipose tissue and insulin resistance in obese","volume":"137","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jceh.2026.103601_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03000605231204462","article-title":"HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population","volume":"51","author":"Zeng","year":"2023","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jceh.2026.103601_bib34","doi-asserted-by":"crossref","first-page":"15429","DOI":"10.2147\/JIR.S532042","article-title":"Glycochenodeoxycholic acid induces the release of IL-1beta from L02 cells via the NLRP3\/caspase-1\/GSDMD pathway to activate LX2 cells","volume":"18","author":"Li","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jceh.2026.103601_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-E","article-title":"Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies","volume":"61","author":"Delzenne","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jceh.2026.103601_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2026.103601_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1907271","article-title":"Completion of the gut microbial epi-bile acid pathway","volume":"13","author":"Doden","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jceh.2026.103601_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.tiv.2012.12.020","article-title":"Bile acids in the colon, from healthy to cytotoxic molecules","volume":"27","author":"Barrasa","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jceh.2026.103601_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2290315","article-title":"Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jceh.2026.103601_bib40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103601_bib41","article-title":"Bacteroides and NAFLD: pathophysiology and therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jceh.2026.103601_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1285982","article-title":"Causal relationship between gut microbiota with subcutaneous and visceral adipose tissue: a bidirectional two-sample mendelian randomization study","volume":"14","author":"Cao","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jceh.2026.103601_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pathogens3010014","article-title":"Metabolism of cholesterol and bile acids by the gut microbiota","volume":"3","author":"G\u00e9rard","year":"2013","journal-title":"Pathogens"},{"key":"10.1016\/j.jceh.2026.103601_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jceh.2026.103601_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1574-6968.2009.01531.x","article-title":"Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces","volume":"293","author":"Fukiya","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jceh.2026.103601_bib46","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000503","article-title":"Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: an observational study","volume":"13","author":"Kasai","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2026.103601_bib47","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12072-023-10610-0","article-title":"Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation","volume":"18","author":"Feng","year":"2024","journal-title":"Hepatol Int"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:45:25Z","timestamp":1791323125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0973688326001337"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103601","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Analysis of Gut Microbiota and Bile Acid Metabolism Reveals a Distinct Pro-fibrotic Profile in Non-obese Patients With Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103601"}}